Aboutme.Profsubin: Short ABBV As It has Already Reached The Target of $100
Aboutme.Profsubin: Short ABBV As It has Already Reached The Target of $100 1. AbbVie is a bio-pharma company founded due to spin-off of Abbot lab. 2. Abbot lab will be specialising in medical devices, equipment for diagnosis, and nutrition products. 3. ABBV will be doing research & development in pharma manufacturing. 4. Listed in NYSE stock exchange. 5. Abbot Lab and ABBV are valued separately. 6. Initially it was having a report that expiry of patent will tend the slowdown in drug division, assumed. 7. If the share drops down to $86.23, then the share will go down. 8. The next target we expect is $81 -$82/share. 9. Revenue is $33.26 Billion. 10. Operating income in 2018 is $6.383 Billion. 11. Net Income is $5.687 Billion. 12. Total Assets is $59.352 Billion. 13. Total Equity is $8.446 Billion. 14. Number of employees is 30000. 15. For best advice on Shares: Contact; +91 7000 188 030 or Like My Page On Quora: Prof Subin According to Miles White, CEO at the time, the purpose of